Lack of association between lysyl oxidase-like 1 polymorphism in pseudoexfoliation syndrome and pseudoexfoliation glaucoma in North Indian population

Abstract

Introduction:

Pseudoexfoliation syndrome is commonly associated with pseudoexfoliation glaucoma. The two nonsynonymous single-nucleotide polymorphisms rs1048661 (R141L) and rs3825942 (G153D) within exon 1 of LOXL1 gene have been found to confer risk of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in different geographical populations. This study aims to find association between two nonsynonymous single-nucleotide polymorphisms with pseudoexfoliation syndrome and pseudoexfoliation glaucoma in North Indian population.

Methods:

North Indian subjects clinically diagnosed with pseudoexfoliation syndrome/pseudoexfoliation glaucoma and normal age-matched control were enrolled in the study. Genomic DNA was extracted and the two single-nucleotide polymorphisms of LOXL1 gene were genotyped by polymerase chain reaction and sequencing. The association between single-nucleotide polymorphisms with pseudoexfoliation syndrome/pseudoexfoliation glaucoma was evaluated by chi-square test.

Results:

A total of 30 pseudoexfoliation glaucoma, 27 pseudoexfoliation syndrome and 61 control subjects were enrolled in the study. Patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma did not show any genetic association with either single-nucleotide polymorphism rs1048661 or rs3825942.

Conclusion:

The study shows lack of association between LOXL1 single-nucleotide polymorphisms and pseudoexfoliation in North Indian population.

Keywords

Lysyl oxidase-like 1 pseudoexfoliation single-nucleotide polymorphism glaucoma XFS LOXL1

Get full access to this article

View all access options for this article.

References

Streeten

Wallace

et al . Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992; 110(12): 1757–1762.

Schlotzer-Schrehardt

Koca

Naumann

et al . Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992; 110(12): 1752–1756.

Barbaud

Trechot

Reichert-Penetrat

et al . Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45(5): 265–268.

Henry

Krupin

Schmitt

et al . Long-term follow-up of pseudoexfoliation and the development of elevated intraocular pressure. Ophthalmology 1987; 94(5): 545–552.

Shakya

Dulal

Maharjan

IM.

Pseudoexfoliation syndrome in various ethnic population of Nepal. Nepal Med Coll J 2008; 10(3): 147–150.

Schlotzer-Schrehardt

Genetics and genomics of pseudoexfoliation syndrome/glaucoma. Middle East Afr J Ophthalmol 2011; 18(1): 30–36.

Ritch

Exfoliation syndrome – the most common identifiable cause of open-angle glaucoma. J Glaucoma 1994; 3(2): 176–177.

Schlotzer-Schrehardt

Hammer

Krysta

et al . LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma. Ophthalmology 2012; 119(9): 1832–1843.

Zenkel

Krysta

Pasutto

et al . Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 2011; 52(11): 8488–8495.

10.

Liu

Zhao

Gao

et al . Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet 2004; 36(2): 178–182.

11.

Wagenseil

Mecham

RP.

New insights into elastic fiber assembly. Birth Defects Res C Embryo Today 2007; 81(4): 229–240.

12.

Thorleifsson

Magnusson

Sulem

et al . Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007; 317(5843): 1397–1400.

13.

Malukiewicz

Lesiewska-Junk

Linkowska

et al . Analysis of LOXL1 single nucleotide polymorphisms in Polish population with pseudoexfoliation syndrome. Acta Ophthalmol 2011; 89(1): e64–e66.

14.

Pasutto

Krumbiegel

Mardin

et al . Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2008; 49(4): 1459–1463.

15.

Mossböck

Renner

Faschinger

et al . Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population. Mol Vis 2008; 14: 857–861.

16.

Aragon-Martin

Ritch

Liebmann

et al . Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol Vis 2008; 14: 533–541.

17.

Challa

Schmidt

Liu

et al . Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis 2008; 14: 146–149.

18.

Micheal

Khan

Akhtar

et al . Role of lysyl oxidase-like 1 gene polymorphisms in Pakistani patients with pseudoexfoliative glaucoma. Mol Vis 2012; 18: 1040–1044.

19.

Abu-Amero

Osman

Dewedar

et al . Analysis of LOXL1 polymorphisms in a Saudi Arabian population with pseudoexfoliation glaucoma. Mol Vis 2010; 16: 2805–2810.

20.

Ramprasad

George

Soumittra

et al . Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis 2008; 14: 318–322.

21.

Chen

Jia

Wang

et al . Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population. Mol Vis 2009; 15: 2349–2357.

22.

Lee

Thalamuthu

et al . Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese. Mol Vis 2009; 15: 1120–1126.

23.

Mabuchi

Sakurada

Kashiwagi

et al . Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome. Mol Vis 2008; 14: 1303–1308.

24.

Sagong

Cha

SC.

Association of lysyl oxidase-like 1 gene polymorphisms with exfoliation syndrome in Koreans. Mol Vis 2011; 17: 2808–2817.

25.

Ringvold

Epidemiology of the pseudo-exfoliation syndrome. Acta Ophthalmol Scand 1999; 77(4): 371–375.

26.

Hashemi

Khabazkhoob

Emamian

et al . The prevalence of exfoliation syndrome in an Iranian population aged 45-69 years. Ophthalmic Epidemiol 2016; 23(5): 303–308.

27.

Lee

Wong

SL.

Pseudoexfoliation syndrome at a Singapore eye clinic. Clin Ophthalmol 2015; 9: 1619–1624.

28.

Grodum

Heijl

Bengtsson

Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology 2005; 112(3): 386–390.

29.

Ozaki

Lee

Vithana

et al . Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci 2008; 49(9): 3976–3980.

30.

Rautenbach

Bardien

Harvey

et al . An investigation into LOXL1 variants in black South African individuals with exfoliation syndrome. Arch Ophthalmol 2011; 129(2): 206–210.

31.

Williams

Whigham

Liu

et al . Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Mol Vis 2010; 16: 705–712.

32.

Chen

Zhang

et al . Ethnicity-based subgroup meta-analysis of the association of LOXL1 polymorphisms with glaucoma. Mol Vis 2010; 16: 167–177.

33.

Schlotzer-Schrehardt

Pasutto

Sommer

et al . Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol 2008; 173(6): 1724–1735.

34.

Zhu

Associations of polymorphisms of LOXL1 gene with primary open-angle glaucoma: a meta-analysis based on 5,293 subjects. Mol Vis 2015; 21: 165–172.

35.

Wen

et al . The association of LOXL1 polymorphisms with exfoliation syndrome/glaucoma: meta-analysis. Int J Ophthalmol 2015; 8(1): 148–156.

36.

Asfuroglu

Cavdarli

Koz

et al . Association of lysyl oxidase-like 1 gene polymorphism in Turkish patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Glaucoma 2017; 26(2): e54–e57.

37.

Aung

Ozaki

Lee

et al . Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. Nat Genet 2017; 49(7): 993–1004.